GRACE
Generalized Risk Adjusted Cost-Effectiveness (GRACE)
Valuing Patient Perspective
Schaeffer Scholars have developed a patient-centric cost-effectiveness model that provides a more effective means of calculating the value of care.
Related Topics
Featured Article
A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)
By recognizing that health is worth more to those who have less, GRACE provides a more equitable approach to value assessment and healthcare investments.
Experts: Darius Lakdawalla, Stephanie Hedt, Barry Liden
Top Stories View All
Perspective
When Cost-Effectiveness Thresholds Drift: Global HTA, MFN Pricing, and the Need for a Coherent Framework
Featured Experts: William Padula
In The News View All
Pink Sheet
Chen warns MFN could have unintended consequences and highlights need for US value-based pricing
Featured Experts: Alice Chen
Bloomberg
Lakdawalla argues for a drug pricing system aligned with American values
Featured Experts: Darius Lakdawalla
STAT
Equity should be reflected in assessments of treatment value, Lakdawalla says
Featured Experts: Darius Lakdawalla
